東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Quantifying Cancer Patient Survival ...

Andersson, Therese M-L.

FindBook

Google Book

Amazon

博客來

Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation./
作者:	Andersson, Therese M-L.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2013,
面頁冊數:	67 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
Contained By:	Dissertations Abstracts International83-03B.
標題:	Medical diagnosis. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28423672
ISBN:	9798744408596

Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation.
Andersson, Therese M-L.

Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation. - Ann Arbor : ProQuest Dissertations & Theses, 2013 - 67 p.

Source: Dissertations Abstracts International, Volume: 83-03, Section: B.

Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2013.

Cancer patient survival is the single most important measure of cancer patient care. By quantifying cancer patient survival in different ways further insights can be gained in terms of temporal trends and differences in cancer patient survival between groups. The objective of this thesis is to develop and apply methods for estimating the cure proportion and loss in expectation of life for cancer patients.In paper I, a cure model was used to study temporal trends in survival of patients with acute myeloid leukaemia in Sweden. Cancer patient survival was estimated in a relative survival setting and quantified as the proportion cured and the median survival time of uncured for different age groups and by calendar time of diagnosis. We found a dramatic increase in the cure proportion for the age group 19-40, although almost no improvement was seen for patients aged 70-79 at diagnosis.In paper II, a flexible parametric cure model was developed to overcome some limitations with standard parametric cure models. This model is a special case of a non-mixture cure model, using splines instead of a parametric distribution for the modeling. The fit of the flexible parametric cure model was compared to the fit of a Weibull non-mixture cure model, and shown to be superior in cases when the standard non-mixture cure model did not give a good fit or did not converge. Software was developed to enable use of the method.In paper III, the possibility of using a flexible parametric relative survival model for estimating life expectancy and loss in expectation of life was evaluated. Extrapolation of the survival function is generally needed, and the flexible parametric relative survival model was shown to extrapolate the survival very well. The method was evaluated by comparing survival functions extrapolated from 10 years past diagnosis to observed survival by the use of data with 40 years of follow-up. Software was developed to enable use of the method.In paper IV, the life expectancy and loss in expectation of life was estimated for colon cancer patients in Sweden. Even though relative survival was similar across age for colon cancer patients, the loss in expectation of life varied greatly by age, since young patients have more years to lose. We also found that the life expectancy of colon cancer patients improved over time. However, the improvement has to a large extent mimicked the improvement seen in the general population, and therefore there were no large changes in the loss in expectation of life.In conclusion, the methods presented in this thesis are additional tools for estimating and quantifying population-based cancer patient survival, that can lead to an improved understanding of different aspects of the prognosis of cancer patients.

ISBN: 9798744408596Subjects--Topical Terms:

3684625
Medical diagnosis.

Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation.
LDR:03932nmm a2200349 4500 001 2400764
005 20240930130028.5
006 m o d
007 cr#unu||||||||
008 251215s2013 ||||||||||||||||| ||eng d
020 $a 9798744408596
035 $a (MiAaPQ)AAI28423672
035 $a (MiAaPQ)Karolinska_1061641668
035 $a AAI28423672
040 $a MiAaPQ $c MiAaPQ
100 1 $a Andersson, Therese M-L. $3 3770818
245 1 0 $a Quantifying Cancer Patient Survival : Extensions and Applications of Cure Models and Life Expectancy Estimation.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2013
300 $a 67 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
500 $a Includes supplementary digital materials.
500 $a Advisor: Lambert, Paul;Dickman, Paul;Lambe, Mats.
502 $a Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2013.
520 $a Cancer patient survival is the single most important measure of cancer patient care. By quantifying cancer patient survival in different ways further insights can be gained in terms of temporal trends and differences in cancer patient survival between groups. The objective of this thesis is to develop and apply methods for estimating the cure proportion and loss in expectation of life for cancer patients.In paper I, a cure model was used to study temporal trends in survival of patients with acute myeloid leukaemia in Sweden. Cancer patient survival was estimated in a relative survival setting and quantified as the proportion cured and the median survival time of uncured for different age groups and by calendar time of diagnosis. We found a dramatic increase in the cure proportion for the age group 19-40, although almost no improvement was seen for patients aged 70-79 at diagnosis.In paper II, a flexible parametric cure model was developed to overcome some limitations with standard parametric cure models. This model is a special case of a non-mixture cure model, using splines instead of a parametric distribution for the modeling. The fit of the flexible parametric cure model was compared to the fit of a Weibull non-mixture cure model, and shown to be superior in cases when the standard non-mixture cure model did not give a good fit or did not converge. Software was developed to enable use of the method.In paper III, the possibility of using a flexible parametric relative survival model for estimating life expectancy and loss in expectation of life was evaluated. Extrapolation of the survival function is generally needed, and the flexible parametric relative survival model was shown to extrapolate the survival very well. The method was evaluated by comparing survival functions extrapolated from 10 years past diagnosis to observed survival by the use of data with 40 years of follow-up. Software was developed to enable use of the method.In paper IV, the life expectancy and loss in expectation of life was estimated for colon cancer patients in Sweden. Even though relative survival was similar across age for colon cancer patients, the loss in expectation of life varied greatly by age, since young patients have more years to lose. We also found that the life expectancy of colon cancer patients improved over time. However, the improvement has to a large extent mimicked the improvement seen in the general population, and therefore there were no large changes in the loss in expectation of life.In conclusion, the methods presented in this thesis are additional tools for estimating and quantifying population-based cancer patient survival, that can lead to an improved understanding of different aspects of the prognosis of cancer patients.
590 $a School code: 0658.
650 4 $a Medical diagnosis. $3 3684625
650 4 $a Patients. $3 1961957
650 4 $a Medical prognosis. $3 3561728
650 4 $a Metastasis. $3 818532
650 4 $a Life expectancy. $3 900290
650 4 $a Lung cancer. $3 3561819
650 4 $a Leukemia. $3 677274
650 4 $a Mortality. $3 533218
650 4 $a Prostate cancer. $3 3561782
650 4 $a Skin cancer. $3 3691696
650 4 $a Tumors. $3 893964
650 4 $a Performance evaluation. $3 3562292
650 4 $a Survival analysis. $3 3566266
650 4 $a Calendars. $3 879487
650 4 $a Breast cancer. $3 3543523
650 4 $a Aging. $3 543123
650 4 $a Gerontology. $3 533633
650 4 $a Morphology. $3 591167
650 4 $a Population. $3 518693
650 4 $a Statistical methods. $3 731085
690 $a 0493
690 $a 0287
690 $a 0351
710 2 $a Karolinska Institutet (Sweden). $3 3557748
773 0 $t Dissertations Abstracts International $g 83-03B.
790 $a 0658
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28423672